Abstract
At times psychotropic drug use is required to address behavioral and other interfering symptoms that accompany neurobehavioral disorders. We review such prescribing practice in autism spectrum disorder, fragile X syndrome, and Prader-Willi syndrome.
Keywords:
Autism; Fragile X syndrome; Prader–Willi syndrome; Psychopharmacology.
Copyright © 2019 Elsevier B.V. All rights reserved.
MeSH terms
-
Antidepressive Agents / therapeutic use
-
Antipsychotic Agents / therapeutic use
-
Autism Spectrum Disorder / diagnosis
-
Autism Spectrum Disorder / drug therapy*
-
Autism Spectrum Disorder / psychology*
-
Fragile X Syndrome / diagnosis
-
Fragile X Syndrome / drug therapy*
-
Fragile X Syndrome / psychology*
-
Humans
-
Intellectual Disability / diagnosis
-
Intellectual Disability / drug therapy
-
Intellectual Disability / psychology
-
Mental Disorders / diagnosis
-
Mental Disorders / drug therapy
-
Mental Disorders / psychology
-
Prader-Willi Syndrome / diagnosis
-
Prader-Willi Syndrome / drug therapy*
-
Prader-Willi Syndrome / psychology*
-
Psychopharmacology
Substances
-
Antidepressive Agents
-
Antipsychotic Agents